sysa1801
cspc pharmaceuticals,elevation oncology
['eo-3021', 'elevation oncology']
today we released promising clinical data for eo-3021 that demonstrated early signs of efficacy in patients with advanced solid #tumors expressing #claudin 18.2. see the full data: #asco2023 
We are focused on discovering and developing selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.